Immuron Limited (IMRN)
NASDAQ: IMRN · Real-Time Price · USD
2.120
-0.150 (-6.61%)
Oct 9, 2025, 4:00 PM EDT - Market closed
Immuron Market Cap
Immuron has a market cap or net worth of $16.08 million as of October 9, 2025. Its market cap has increased by 12.42% in one year.
Market Cap
16.08M
Enterprise Value
12.29M
1-Year Change
12.42%
Ranking
Category
Stock Price
$2.12
Market Cap Chart
Since June 9, 2017, Immuron's market cap has decreased from $28.10M to $16.08M, a decrease of -42.79%. That is a compound annual growth rate of -6.48%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2025 | 12.90M | 32.99% |
| Dec 31, 2024 | 9.70M | -9.35% |
| Dec 29, 2023 | 10.70M | -9.32% |
| Dec 30, 2022 | 11.80M | -16.90% |
| Dec 31, 2021 | 14.20M | -50.00% |
| Dec 31, 2020 | 28.40M | 91.89% |
| Dec 31, 2019 | 14.80M | -28.50% |
| Dec 31, 2018 | 20.70M | 20.35% |
| Dec 29, 2017 | 17.20M | -38.79% |
| Jun 9, 2017 | 28.10M | - |
View and export this data all the way back to 2017. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 758.63B |
| Johnson & Johnson | 453.15B |
| AbbVie | 406.64B |
| UnitedHealth Group | 324.93B |
| Novo Nordisk | 269.41B |
| AstraZeneca | 265.89B |
| Novartis AG | 257.47B |
| Abbott Laboratories | 232.77B |